Back To Archive

This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link and also the OMNS archive link are included.

Orthomolecular Medicine News Service, November 30, 2023

A-Fib, Potassium and Magnesium

A Personal Report by Dwight Kalita, PhD

OMNS (November 30, 2023) Atrial fibrillation (Afib) is a worldwide epidemic affecting 37 million people, and its rising prevalence will most certainly account for increasing public health costs. I am 76 years old and have had A-fib for almost 10 years. During that time various cardiologists gave me 2 ablations and 5 cardioversions, but the Afib always returned. I have been on numerous drugs, all of which caused serious side effects and none of which ever cured my Afib.

From 11/3/2022 to 11/10/22, my heart monitor recorded a 6% burden of A-fib episodes with a 150bpm maximum rate. These on-and-off episodes continued despite taking Dofetilide (antiarrhythmic) and Diltiazem (calcium channel blocker for blood pressure) since April 22, 2022. In April, 2023 I read a European medical article "Association of IV Potassium and Magnesium Administration with Spontaneous Conversion of A-Fib in the ER Department" in JAMA Oct. 2022. After thinking about this article, I decided to see if the combined, oral administration of magnesium (Mg), potassium (K), and Dofetilide would help prevent my chronic A-fib episodes that I have experienced for almost 10 years.

I began taking the following around April 15, 2023: electrolyte powder: one scoop per day of 1000 mgs potassium citrate, 120 mgs magnesium citrate, plus very small amounts of other mineral complexes. I have been taking 500 mgs of magnesium taurate orally for 5-6 years but continued to experience on and off Afib episodes. When I had an episode that lasted more than 20 minutes, I took 2 grams of magnesium IV and that always converted me back to sinus rhythm. Then I read the above JAMA article about IV magnesium and potassium together converting ER Afib patients in Europe so I began taking both nutrients orally. That oral combo nutrient program of magnesium and potassium is what really eliminated my Afib!

Within one week of taking the above mineral supplements with Dofetilide, my heart palpitations and A-fib episodes disappeared. My two EKG "sinus" reports since beginning K and Mg supplements confirm this observation as well as home-Kardia monitoring. I have also not needed to take any 2-gram magnesium IV treatments to convert my A-fib episodes since I have not had any episodes for the last 6 months. I eliminated Diltiazem because of stomach pain and diarrhea side effects; but my blood pressure has actually improved since the introduction of the K1000 potassium supplement.

My quarterly blood work measuring Mg/K remains within normal levels since beginning the mineral supplementation program. My local cardiologist as well as one at the Cleveland Clinic both approve of my new drug/nutrient treatment plan. And best of all since beginning this treatment plan, I have had no side effects and no more A-fib episodes whatsoever. It is now very clear to me that my 76-year-old heart cells need extra magnesium/potassium supplementation in order to live a life free of the very debilitating disease called atrial fibrillation.

(Readers may contact Dwight Kalita at

Related reading:

Khan AM, Lubitz SA, Sullivan LM, et al. Low Serum Magnesium and the Development of Atrial Fibrillation in the Community: The Framingham Heart Study. Circulation. 2013; 127 (1): 33-38.

Dean C. Atrial Fibrillation: Remineralize Your Heart, 2015.

Nutritional Medicine is Orthomolecular Medicine

Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information:

Find a Doctor

To locate an orthomolecular physician near you:

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.

Editorial Review Board:

Albert G. B. Amoa, MB.Ch.B, Ph.D. (Ghana)
Seth Ayettey, M.B., Ch.B., Ph.D. (Ghana)
Ilyès Baghli, M.D. (Algeria)
Barry Breger, M.D. (Canada)
Ian Brighthope, MBBS, FACNEM (Australia)
Gilbert Henri Crussol, D.M.D. (Spain)
Carolyn Dean, M.D., N.D. (USA)
Ian Dettman, Ph.D. (Australia)
Susan R. Downs, M.D., M.P.H. (USA)
Ron Ehrlich, B.D.S. (Australia)
Hugo Galindo, M.D. (Colombia)
Gary S. Goldman, Ph.D. (USA)
William B. Grant, Ph.D. (USA)
Claus Hancke, MD, FACAM (Denmark)
Patrick Holford, BSc (United Kingdom)
Ron Hunninghake, M.D. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Dwight Kalita, Ph.D. (USA)
Felix I. D. Konotey-Ahulu, M.D., FRCP (Ghana)
Peter H. Lauda, M.D. (Austria)
Fabrice Leu, N.D., (Switzerland)
Alan Lien, Ph.D. (Taiwan)
Homer Lim, M.D. (Philippines)
Stuart Lindsey, Pharm.D. (USA)
Pedro Gonzalez Lombana, M.D., Ph.D. (Colombia)
Victor A. Marcial-Vega, M.D. (Puerto Rico)
Juan Manuel Martinez, M.D. (Colombia)
Mignonne Mary, M.D. (USA)
Joseph Mercola, D.O. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Sarah Myhill, MB, BS (United Kingdom)
Tahar Naili, M.D. (Algeria)
Zhiyong Peng, M.D. (China)
Isabella Akyinbah Quakyi, Ph.D. (Ghana)
Selvam Rengasamy, MBBS, FRCOG (Malaysia)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Thomas N. Seyfried, Ph.D. (USA)
Han Ping Shi, M.D., Ph.D. (China)
T.E. Gabriel Stewart, M.B.B.CH. (Ireland)
Jagan Nathan Vamanan, M.D. (India)

Andrew W. Saul, Ph.D. (USA), Editor-In-Chief
Associate Editor: Robert G. Smith, Ph.D. (USA)
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA)
Editor, Norwegian Edition: Dag Viljen Poleszynski, Ph.D. (Norway)
Editor, Arabic Edition: Moustafa Kamel, R.Ph, P.G.C.M (Egypt)
Editor, Korean Edition: Hyoungjoo Shin, M.D. (South Korea)
Editor, Spanish Edition: Sonia Rita Rial, PhD (Argentina)
Editor, German Edition: Bernhard Welker, M.D. (Germany)
Associate Editor, German Edition: Gerhard Dachtler, M.Eng. (Germany)
Assistant Editor: Michael Passwater (USA)
Contributing Editor: Thomas E. Levy, M.D., J.D. (USA)
Contributing Editor: Damien Downing, M.B.B.S., M.R.S.B. (United Kingdom)
Contributing Editor: W. Todd Penberthy, Ph.D. (USA)
Contributing Editor: Ken Walker, M.D. (Canada)
Contributing Editor: Michael J. Gonzalez, N.M.D., Ph.D. (Puerto Rico)
Technology Editor: Michael S. Stewart, B.Sc.C.S. (USA)
Associate Technology Editor: Robert C. Kennedy, M.S. (USA)
Legal Consultant: Jason M. Saul, JD (USA)

Comments and media contact: OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.

To Subscribe at no charge:

To Unsubscribe from this list:

Back To Archive

[Home] [History] [Library] [Nutrients] [Resources] [Contact] [Contribute]
Back To Molecule

This website is managed by Riordan Clinic
A Non-profit 501(c)(3) Medical, Research and Educational Organization
3100 North Hillside Avenue, Wichita, KS 67219 USA
Phone: 316-682-3100; Fax: 316-682-5054
© (Riordan Clinic) 2004 - 2017

Information on is provided for educational purposes only. It is not intended as medical advice.
Consult your orthomolecular health care professional for individual guidance on specific health problems.